These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The anatomical basis for segment III cholangiojejunostomy with analysis of 13 cases. Vellar ID; Banting SW; Hardy KJ Aust N Z J Surg; 1998 Jul; 68(7):498-503. PubMed ID: 9669363 [TBL] [Abstract][Full Text] [Related]
5. Combined biliary and gastric bypass procedures as effective palliation for unresectable malignant disease. Mann CD; Thomasset SC; Johnson NA; Garcea G; Neal CP; Dennison AR; Berry DP ANZ J Surg; 2009 Jun; 79(6):471-5. PubMed ID: 19566872 [TBL] [Abstract][Full Text] [Related]
7. Palliative segment III biliary bypass (left cholangio-jejunostomy) in malignant block at porta hepatis. Jagannath P; Bhansali MS; Desouza LJ; Swaroop VS; Mohandas KM Indian J Gastroenterol; 1992 Apr; 11(2):71-2. PubMed ID: 1385325 [TBL] [Abstract][Full Text] [Related]
8. Right trisectionectomy with principle en bloc portal vein resection for right-sided hilar cholangiocarcinoma: no-touch technique. Machado MA; Makdissi FF; Surjan RC Ann Surg Oncol; 2012 Apr; 19(4):1324-5. PubMed ID: 21997349 [TBL] [Abstract][Full Text] [Related]
9. Left intrahepatic cholangio-enteric anastomosis (round ligament approach): an effective palliative treatment for hilar cancers. Traynor O; Castaing D; Bismuth H Br J Surg; 1987 Oct; 74(10):952-4. PubMed ID: 2444310 [TBL] [Abstract][Full Text] [Related]
10. A new technique for the palliative treatment of high bile duct cancer. Safioleas MC Hepatogastroenterology; 2005; 52(62):378-80. PubMed ID: 15816440 [TBL] [Abstract][Full Text] [Related]
11. Unresectable hilar cholangiocarcinoma: multimodality approach with percutaneous treatment associated with radiotherapy and chemotherapy. Golfieri R; Giampalma E; Renzulli M; Galuppi A; Vicenzi L; Galaverni MC; Cappelli A In Vivo; 2006; 20(6A):757-60. PubMed ID: 17203762 [TBL] [Abstract][Full Text] [Related]
12. Palliative treatment with radiation-emitting metallic stents in unresectable Bismuth type III or IV hilar cholangiocarcinoma. Lu J; Guo JH; Zhu HD; Zhu GY; Wang Y; Zhang Q; Chen L; Wang C; Pan TF; Teng GJ ESMO Open; 2017; 2(4):e000242. PubMed ID: 29018577 [TBL] [Abstract][Full Text] [Related]
13. The need for a prophylactic gastrojejunostomy for unresectable periampullary cancer: a prospective randomized multicenter trial with special focus on assessment of quality of life. Van Heek NT; De Castro SM; van Eijck CH; van Geenen RC; Hesselink EJ; Breslau PJ; Tran TC; Kazemier G; Visser MR; Busch OR; Obertop H; Gouma DJ Ann Surg; 2003 Dec; 238(6):894-902; discussion 902-5. PubMed ID: 14631226 [TBL] [Abstract][Full Text] [Related]
14. Palliative treatment in patients with unresectable hilar cholangiocarcinoma: results of endoscopic drainage in patients with type III and IV hilar cholangiocarcinoma. Gerhards MF; den Hartog D; Rauws EA; van Gulik TM; González González D; Lameris JS; de Wit LT; Gouma DJ Eur J Surg; 2001 Apr; 167(4):274-80. PubMed ID: 11354319 [TBL] [Abstract][Full Text] [Related]
15. Guidelines for palliative surgery of cholangiocarcinoma. Witzigmann H; Lang H; Lauer H HPB (Oxford); 2008; 10(3):154-60. PubMed ID: 18773044 [TBL] [Abstract][Full Text] [Related]
16. Clinical experience in 126 patients with tissue-proved proximal cholangiocarcinoma. Wang YJ; Lee SD; Shyu JK; Lo KJ J Gastroenterol Hepatol; 1994; 9(2):134-7. PubMed ID: 8003645 [TBL] [Abstract][Full Text] [Related]